OBJECTIVE: In early cervical cancer, a total pelvic lymphadenectomy is the standard of care, even though most patients have negative nodes and thus undergo lymphadenectomy unnecessarily. Although the value of sentinel lymph node (SLN) mapping in early-stage cervical cancer has not yet been established, near-infrared (NIR) fluorescence imaging is a promising technique to perform this procedure. Near-infrared fluorescence imaging is based on invisible NIR light and can provide high sensitivity, high-resolution, and real-time image guidance during surgery. METHODS: Clinical trial subjects were 9 consecutive cervical cancer patients undergoing total pelvic lymphadenectomy. Before surgery, 1.6 mL of indocyanine green adsorbed to human serum albumin (ICG:HSA) was injected transvaginally and submucosally in 4 quadrants around the tumor. Patients were allocated to 500-, 750-, or 1000-μM ICG:HSA concentration groups. The Mini-FLARE imaging system was used for NIR fluorescence detection and quantitation. RESULTS: Sentinel lymph nodes were identified in all 9 patients. An average of 3.4 ± 1.2 SLNs was identified per patient. No differences in signal to background of the SLNs between the 500-, 750-, and 1000-μM dose groups were found (P = 0.73). In 2 patients, tumor-positive lymph nodes were found. In both patients, tumor-positive lymph nodes confirmed by pathology were also NIR fluorescent. CONCLUSIONS: This study demonstrated preliminary feasibility to successfully detect SLNs in cervical cancer patients using ICG:HSA and the Mini-FLARE imaging system. When considering safety, cost-effectiveness, and pharmacy preferences, an ICG:HSA concentration of 500 μM was optimal for SLN mapping in cervical cancer patients.
OBJECTIVE: In early cervical cancer, a total pelvic lymphadenectomy is the standard of care, even though most patients have negative nodes and thus undergo lymphadenectomy unnecessarily. Although the value of sentinel lymph node (SLN) mapping in early-stage cervical cancer has not yet been established, near-infrared (NIR) fluorescence imaging is a promising technique to perform this procedure. Near-infrared fluorescence imaging is based on invisible NIR light and can provide high sensitivity, high-resolution, and real-time image guidance during surgery. METHODS: Clinical trial subjects were 9 consecutive cervical cancerpatients undergoing total pelvic lymphadenectomy. Before surgery, 1.6 mL of indocyanine green adsorbed to humanserum albumin (ICG:HSA) was injected transvaginally and submucosally in 4 quadrants around the tumor. Patients were allocated to 500-, 750-, or 1000-μM ICG:HSA concentration groups. The Mini-FLARE imaging system was used for NIR fluorescence detection and quantitation. RESULTS: Sentinel lymph nodes were identified in all 9 patients. An average of 3.4 ± 1.2 SLNs was identified per patient. No differences in signal to background of the SLNs between the 500-, 750-, and 1000-μM dose groups were found (P = 0.73). In 2 patients, tumor-positive lymph nodes were found. In both patients, tumor-positive lymph nodes confirmed by pathology were also NIR fluorescent. CONCLUSIONS: This study demonstrated preliminary feasibility to successfully detect SLNs in cervical cancerpatients using ICG:HSA and the Mini-FLARE imaging system. When considering safety, cost-effectiveness, and pharmacy preferences, an ICG:HSA concentration of 500 μM was optimal for SLN mapping in cervical cancerpatients.
Authors: Charles Levenback; Robert L Coleman; Thomas W Burke; W Michael Lin; William Erdman; Michael Deavers; Ebrahim S Delpassand Journal: J Clin Oncol Date: 2002-02-01 Impact factor: 44.544
Authors: Lucas B Silva; Agnaldo L Silva-Filho; Paulo Traiman; Sérgio A Triginelli; Carla Flávia de Lima; Cristiano Ferrari Siqueira; Adelanir Barroso; Telma Maria F F Rossi; Moises Salgado Pedrosa; Dairton Miranda; José Renan Cunha Melo Journal: Gynecol Oncol Date: 2005-05 Impact factor: 5.482
Authors: Shunsuke Ohnishi; Stephen J Lomnes; Rita G Laurence; Andrew Gogbashian; Giuliano Mariani; John V Frangioni Journal: Mol Imaging Date: 2005 Jul-Sep Impact factor: 4.488
Authors: Raimund Winter; Josef Haas; Olaf Reich; Rudolf Koemetter; Karl Tamussino; Manfred Lahousen; Edgar Petru; Hellmuth Pickel Journal: Gynecol Oncol Date: 2002-02 Impact factor: 5.482
Authors: Q D Pieterse; G G Kenter; K N Gaarenstroom; A A W Peters; S M Willems; G J Fleuren; J B M Z Trimbos Journal: Eur J Surg Oncol Date: 2006-11-13 Impact factor: 4.424
Authors: Alexander L Vahrmeijer; Merlijn Hutteman; Joost R van der Vorst; Cornelis J H van de Velde; John V Frangioni Journal: Nat Rev Clin Oncol Date: 2013-07-23 Impact factor: 66.675
Authors: Aaron M Mohs; Michael C Mancini; James M Provenzale; Corey F Saba; Karen K Cornell; Elizabeth W Howerth; Shuming Nie Journal: IEEE Trans Biomed Eng Date: 2015-01-09 Impact factor: 4.538
Authors: Joost R van der Vorst; Boudewijn E Schaafsma; Floris P R Verbeek; Stijn Keereweer; Jeroen C Jansen; Lilly-Ann van der Velden; Antonius P M Langeveld; Merlijn Hutteman; Clemens W G M Löwik; Cornelis J H van de Velde; John V Frangioni; Alexander L Vahrmeijer Journal: Oral Oncol Date: 2012-08-28 Impact factor: 5.337
Authors: Jason M Warram; Esther de Boer; Lindsay S Moore; Cecelia E Schmalbach; Kirk P Withrow; William R Carroll; Joshua S Richman; Anthony B Morlandt; Margaret Brandwein-Gensler; Eben L Rosenthal Journal: J Surg Oncol Date: 2015-06-12 Impact factor: 3.454
Authors: Elizabeth L Jewell; Juan Juan Huang; Nadeem R Abu-Rustum; Ginger J Gardner; Carol L Brown; Yukio Sonoda; Richard R Barakat; Douglas A Levine; Mario M Leitao Journal: Gynecol Oncol Date: 2014-02-28 Impact factor: 5.482
Authors: Floris P R Verbeek; Quirijn R J G Tummers; Daphne D D Rietbergen; Alexander A W Peters; Boudewijn E Schaafsma; Cornelis J H van de Velde; John V Frangioni; Fijs W B van Leeuwen; Katja N Gaarenstroom; Alexander L Vahrmeijer Journal: Int J Gynecol Cancer Date: 2015-07 Impact factor: 3.437
Authors: Rutger M Schols; Nicole D Bouvy; Ad A M Masclee; Ronald M van Dam; Cornelis H C Dejong; Laurents P S Stassen Journal: Surg Endosc Date: 2012-10-18 Impact factor: 4.584